Target Price | $121.71 |
Price | $103.99 |
Potential |
17.04%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target HealthEquity Inc 2026 .
The average HealthEquity Inc target price is $121.71.
This is
17.04%
register free of charge
$130.00
25.01%
register free of charge
$104.00
0.01%
register free of charge
|
|
A rating was issued by 15 analysts: 14 Analysts recommend HealthEquity Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the HealthEquity Inc stock has an average upside potential 2026 of
17.04%
register free of charge
|
Jan '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion $ | 1.20 | 1.31 |
20.03% | 8.82% | |
EBITDA Margin | 26.23% | 41.71% |
18.71% | 58.99% | |
Net Margin | 8.06% | 13.71% |
44.62% | 70.10% |
14 Analysts have issued a sales forecast HealthEquity Inc 2026 . The average HealthEquity Inc sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an HealthEquity Inc EBITDA forecast 2026. The average HealthEquity Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 HealthEquity Inc Analysts have issued a net profit forecast 2026. The average HealthEquity Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jan '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.09 | 2.06 |
70.31% | 88.99% | |
P/E | 50.36 | |
EV/Sales | 7.48 |
11 Analysts have issued a HealthEquity Inc forecast for earnings per share. The average HealthEquity Inc EPS is
This results in the following potential growth metrics and future valuations:
HealthEquity Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Barrington Research |
Locked
➜
Locked
|
Locked | Jun 05 2025 |
Deutsche Bank |
Locked
➜
Locked
|
Locked | Jun 05 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
Analyst Rating | Date |
---|---|
Locked
Barrington Research:
Locked
➜
Locked
|
Jun 05 2025 |
Locked
Deutsche Bank:
Locked
➜
Locked
|
Jun 05 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Apr 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.